Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheena McCormack

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
AIDS Research and Therapy|November 14, 2023
"Sex without fear": exploring the psychosocial impact of oral HIV pre-exposure prophylaxis on gay men in EnglandRosalie Hayes, Will Nutland, Michael Rayment, et al.
The Lancet. HIV|November 3, 2023
The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysisValentina Cambiano, Alec Miners, Fiona C Lampe, et al.
Sexually Transmitted Infections|May 7, 2010
A randomised placebo-controlled safety and acceptability trial of PRO 2000 vaginal microbicide gel in sexually active women in UgandaAnatoli Kamali, Helen Byomire, Catherine Muwonge, et al.
BMC Public Health|April 27, 2019
Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trialAda R Miltz, Fiona C Lampe, Loraine J Bacchus, et al.
The Lancet. Infectious Diseases|October 22, 2017
Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluationValentina Cambiano, Alec Miners, David Dunn, et al.
Journal of Clinical Microbiology|February 27, 2009
Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settingsDean B Everett, Kathy Baisley, John Changalucha, et al.
Plos One|May 8, 2026
Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018-2022 HIV vaccine preparedness cohort in Masaka, UgandaSylvia Kusemererwa, Sheila Kansiime, Gertrude Mutonyi, et al.
HIV Medicine|March 15, 2019
BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018Michael Brady, Alison Rodger, David Asboe, et al.
Frontiers in Immunology|January 11, 2020
The Safety and Immunogenicity of GTU<sup>®</sup>MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ARTG Haidari, Suzanne Day, M Wood, et al.
Vaccine|September 24, 2005
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersInese Cebere, Lucy Dorrell, Helen McShane, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
AIDS Research and Therapy|November 14, 2023
"Sex without fear": exploring the psychosocial impact of oral HIV pre-exposure prophylaxis on gay men in EnglandRosalie Hayes, Will Nutland, Michael Rayment, et al.
The Lancet. HIV|November 3, 2023
The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysisValentina Cambiano, Alec Miners, Fiona C Lampe, et al.
Sexually Transmitted Infections|May 7, 2010
A randomised placebo-controlled safety and acceptability trial of PRO 2000 vaginal microbicide gel in sexually active women in UgandaAnatoli Kamali, Helen Byomire, Catherine Muwonge, et al.
BMC Public Health|April 27, 2019
Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trialAda R Miltz, Fiona C Lampe, Loraine J Bacchus, et al.
The Lancet. Infectious Diseases|October 22, 2017
Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluationValentina Cambiano, Alec Miners, David Dunn, et al.
Journal of Clinical Microbiology|February 27, 2009
Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settingsDean B Everett, Kathy Baisley, John Changalucha, et al.
Plos One|May 8, 2026
Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018-2022 HIV vaccine preparedness cohort in Masaka, UgandaSylvia Kusemererwa, Sheila Kansiime, Gertrude Mutonyi, et al.
HIV Medicine|March 15, 2019
BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018Michael Brady, Alison Rodger, David Asboe, et al.
Frontiers in Immunology|January 11, 2020
The Safety and Immunogenicity of GTU<sup>®</sup>MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ARTG Haidari, Suzanne Day, M Wood, et al.
Vaccine|September 24, 2005
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersInese Cebere, Lucy Dorrell, Helen McShane, et al.
Pageof 12